======= B3GALT6 ======= == Gene Information == * **Official Symbol**: B3GALT6 * **Official Name**: beta-1,3-galactosyltransferase 6 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=126792|126792]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96L58|Q96L58]] * **Interactions**: [[https://thebiogrid.org/search.php?search=B3GALT6&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20B3GALT6|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615291|Open OMIM]] == Function Summary == * **Entrez Summary**: The enzyme encoded by this intronless gene is a beta-1,3-galactosyltransferase found in the medial Golgi apparatus, where it catalyzes the transfer of galactose from UDP-galactose to substrates containing a terminal beta-linked galactose moiety. The encoded enzyme has a particular affinity for galactose-beta-1,4-xylose found in the linker region of glycosamines. This enzyme is required for glycosaminoglycan synthesis. [provided by RefSeq, Jun 2013]. * **UniProt Summary**: Beta-1,3-galactosyltransferase that transfers galactose from UDP-galactose to substrates with a terminal beta-linked galactose residue. Has a preference for galactose-beta-1,4-xylose that is found in the linker region of glycosaminoglycans, such as heparan sulfate and chondroitin sulfate. Has no activity towards substrates with terminal glucosamine or galactosamine residues. {ECO:0000269|PubMed:11551958}. |Galactosyl T| |galactosylxylosylprotein 3-beta-galactosyltransferase activity| |UDP-galactosyltransferase activity| |UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity| |Golgi medial cisterna| |galactosyltransferase activity| |chondroitin sulfate biosynthetic process| |heparan sulfate proteoglycan biosynthetic process| |chondroitin sulfate proteoglycan biosynthetic process| |heparan sulfate proteoglycan metabolic process| |chondroitin sulfate metabolic process| |chondroitin sulfate proteoglycan metabolic process| |proteoglycan biosynthetic process| |Golgi cisterna membrane| |proteoglycan metabolic process| |glycosaminoglycan biosynthetic process| |mucopolysaccharide metabolic process| |aminoglycan biosynthetic process| |glycosaminoglycan metabolic process| |aminoglycan metabolic process| |sulfur compound biosynthetic process| |protein glycosylation| |macromolecule glycosylation| |glycosylation| |glycoprotein biosynthetic process| |sulfur compound metabolic process| |glycoprotein metabolic process| |carbohydrate derivative biosynthetic process| |Golgi membrane| |Golgi apparatus| |oxoacid metabolic process| |endoplasmic reticulum| |organic acid metabolic process| |carbohydrate derivative metabolic process| |organonitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |small molecule metabolic process| |macromolecule biosynthetic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|1.82| |[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|2.07| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|3.08| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4779 * **Expression level (log2 read counts)**: 4.73 {{:chemogenomics:nalm6 dist.png?nolink |}}